BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2346867)

  • 21. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implementation of the Gynaecological Groupe Européen de Curiethérapie - European Society for Therapeutic Radiology and Oncology radiobiology considerations in the conversion of low dose rate to pulsed dose rate treatment schedules for gynaecological brachytherapy.
    Baker S; Pooler A; Hendry J; Davidson S
    Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):265-71. PubMed ID: 23218875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the linear-quadratic-concept for prediction of late complications after combined irradiation of the uterine cervix.
    Visser PA; Moonen LM; van der Kogel AJ; Keijser AH
    Radiother Oncol; 1985; 4(2):133-41. PubMed ID: 4070679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical experience with short-term afterloading therapy in comparison with conventional brachytherapy in the treatment of gynecologic tumors].
    Glaser FH; Grimm D; Haensgen G; Rauh G; Schuchardt V
    Strahlentherapie; 1985 Aug; 161(8):459-75. PubMed ID: 3927526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
    Armpilia C; Dale RG; Sandilos P; Vlachos L
    Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
    Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
    Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measurement of the radiation load to bladder and rectum in gynecological brachytherapy with a mobile radiation source (author's transl)].
    Busch M
    Strahlentherapie; 1978 Oct; 154(10):681-5. PubMed ID: 694958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weiss lecture. The dose-rate factor in radiation biology.
    Hall EJ
    Int J Radiat Biol; 1991 Mar; 59(3):595-610. PubMed ID: 1672350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
    Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
    Lennernäs B; Albertsson P; Edgren M; Nilsson S
    Oncol Rep; 2007 Nov; 18(5):1299-303. PubMed ID: 17914588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The initial results on the radiobiological comparability of continuous LDR irradiation and PDR irradiation using a guinea pig skin animal model].
    Brock A; Prager W; Pohlmann S; Friedrich K
    Strahlenther Onkol; 1995 Nov; 171(11):641-5. PubMed ID: 7502227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose-rate afterloading and the LQ-model--evaluation of efficacy in cervix cancer therapy.
    Glaser FH; Basche S; Möldner B
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(3-4):639-42. PubMed ID: 2131567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects].
    Grillo Ruggieri F; Parietti E; Bistolfi F; Tomassini E; Papadia S; Leonardi S; Siragusa A; Guglielmi M; Brizzi C; Scielzo G
    Radiol Med; 1989 Oct; 78(4):373-9. PubMed ID: 2595028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.